BI Asset Management Fondsmaeglerselskab A/S
Position in PTCT — Ptc Therapeutics, Inc.
CIK 1778131
KOBENHAVN, G7
Position in PTCT
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$5,578,348
-$6,535,524 QoQ
Shares Held
81,878
-48.7% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BI Asset Management Fondsmaeglerselskab A/S holds $81,144,167 across 10 Biotechnology names. PTCT ranks #6 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,531 | $22,117,572 | |
| 2 | TECH |
BIO-TECHNE Corp
|
316,510 | $16,540,812 | |
| 3 | INCY |
Incyte Corp
|
155,246 | $14,611,753 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
148,752 | $9,613,841 | |
| 5 | EXEL |
Exelixis, Inc.
|
152,320 | $6,533,004 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
This page
|
81,878 | $5,578,348 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,239 | $2,502,580 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,697 | $1,884,966 |
All Filings in PTCT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,578,348 | 81,878 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $12,113,872 | 159,477 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $5,830,456 | 95,005 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $6,159,700 | 126,120 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $60,897 | 1,195 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||